B 24-0952 — Opioid Litigation Proceeds Act of 2022

Ct);and “(D)Inre Mallnckrodt PLC, No.20-B K-12522 (Bakr.

D.Del.);

(B)A new paragraph(1A) isadded t readasfollows “(1A) Funds reeivedby theDistictpursuanttoany pre-orpost-uit settlement,judgment, o consen decreethattheAttorneyGeneral dsignatesasan d setlemen, jdgment, orconsentdecre.’ The Atorney Generl shal iil ‘pioidrelate cil andthe Mayorofan y suchdesignaion wihin 30days ofthe ntifytheCoun gment, orconsentdecreebecomi ngfina;and”.

113, sttlemnt,jud bsction(e)isadded toreadas folows:

() A new su tions(b)(1 and ()(1A)f this sctio, th Attorney 11S “(e)Notwithstaning subsc ayment th Ditric recivespursuantto te Genera may elec tohave aportioof each p eferencd insubsecions ()(1)and (b)1A) setlemens,judgments, andconsentdecreesr nd etablised pusuantto setion ofthi seciondepositedintotheLitigtionSupport Fu iicatin andElectedTer m 106b oftheAttorneyGeneral fo th Ditric ofColum biaClar D.C.Offical Amen dment Act of2010, efectveOctober 22,2015 (D.C.La w 2136;

Code § 1-30.86b).

The Attrney Genera shal make ths eectio by povidingthe Mayor and theChiefFinanial Offier wih writen noiceof th amount oftheelecton and th reevantpayment.

In making tiselecion,theAttorneyGeneral sallensure compliancewith al aplicabl settementterms,includng term speciying te minim um amountofsettlement fund tha must bedevotedto programsand sericesto mtigatethe effcto fthe opiod epideic.

In noevent salltheAttorneyGeneral elctto havemore than1 5% ofany payment depsited itotheLitigaton Spport Fun.”.

()Scto 16bothAttreyGnealfrteDititoColmbi ClriiainanEletdTer AendmntAc o200,efctvOctbe222015 (D..Law1810;DC.OfcilCde§130.6b,iamenedafolos (1Subecin(bisaenddasflow:

(A)Prarah(2ismenedbysrkigtewrd“ad”ath end ()Prarah(3ismenedbysrkigtepridathendad isrigtephas“;ad”iitplc.

()Anewpaagah(4isadetoradafolos “()FudsdretdtorrtanditheFndpusantoscio501 o teOiodAbtemntFudEmegecyEsabihmntAtof222pase o I vrioofBl24-4),othOpiidAbteen Fnd rainonJue7,222(nrled EtalshenActo202,pasdon2nreaigonJue72022(noleverioof Bl2471)” (2.Sbscto ()3(Disaenddtoradafolws “(2Nowihsanigan ohrprvsinothsscio,teAtomy blsepuruattsetin512 Gnealsa tasfrtthOpii AatmetFundet 145ofheOpiidAbteen FndEmrgncyEtalihenActo202,paseonIs radnonJun7,222(ErlldvrsoofBi 2-45,ales85%ofanpayent rcevdprotoOtoer1202,isetlmnofhecaesseifeinscto 512b)1otha attawasdpoieditthLitgtoSuporFun.TheAttme hLitgton Gnealma eettreannomrethn15%oeacsucpaymntit SpprtFnd Imakigthseeto,teAtoreGenrashllesrecmpiace wih alappliablesetlemen tems,incluingtermsspecfyingth minimum amountof setlemet fndsthatmustbe deotedtoprograms ad sevice tomiigat th efect of th opiidepidemc.”.

Se.

4 PermisibleUsesof teOpioid Abtement Fund (a Money i th Opiid Abatemen Fund sal beusedforthefolloing puroses:

(1 Ditric-wid nees assssment toidetif srucura gas andneeds reltedtoopiid ue diorde andco-ocurrin sustanceuseand mntalhealt diordes toinformexpediturs fromtheFund;

(2)Infastuctrerequredforevidene-base andevidenceinforme ,recoery,orharm redctio progams,servces,suport, tol, prevntio, teatmnt dusedisoderandco-occuringsubstnceuse ad menta helth and rsoures fropioi disoder;

dresorcesforevience-baed (3)Progrms, srvies,suports tols an oery,orharm redctio foropoiduse and evdence-iformedprevntio, tratmnt,rec disorerand cooccuringsubstane ue andmenta heathdisoders (4)(A Evidnce-infored prventon,treament reover, o harm redutionpiltprogramsordemonstationstudesforopiod us disrderandco- occuringsubstnceuse an menta helthdisoderstha aenot eidence-asedbutare approve by teM ayorasan aproprateuse o mones fo alimtedperio oftimea.

speifie bytheMayor;

(B) I cnsideingevidenceinforme piotprogramsand demonstration studies,the Commission and the Mayor shallassess whether the emerging eidecesupotsdstiuto omonisforschuss oothrwsewhthe terisa rasnabebaisfrfudigsuchueswihth epetaioofceatnga eidncebse frsucuse;

stucue, (5)Ealutinsofefctveesandoutome rpotigfoinra piidus dsodeandco prgrms srvcs,spprt,tol,andrsorcsfoo alheat dsodrsfrwhih mnie fomthFund ocurinsubsaneuseadment isuredsucha ipatonaccsst hrmreucio,sevie,ortratenfor weed diodes oredctonindugreaedmrtliy (6OneormoredaaineraesmaagedbythMayortoagrgae,tak, andrpotfreofchrgean aalaleolietotepuli,daaonopoi uediorer andc-ocurinsubtaneus admentlheltdisrdr,ovedoes addrg-elte hars;spndigrecmmedaion,plasandrpotsandoutome oproram, sevie,supotstoosandreouce frwhchmonesfromteFundweedisured ()Anyothropoi aatmen atvtisathriedbyan jdgent conen dcee osetleenreslininfudstob dpoitdinothFund ad (bUnlssoterwserqure bconroligcortode trefndtthefeeal govrnmetaporiooftheltgainprcedsdeoste ith Fnd,mniesitheFud s shllb uedfopropetiepurossandshlnotbeuedtorimbrs epediur incrrdpro tth efctvedteothiAct (©Monis epenedfro teFun frthpurose stfrtinsusetin(a 194 shllb sppemeta t,adshalnosuplatortaethplaeofanyoterfnd, incudnginurncbenftsorDsrito fdrafunin,thtwoul ohewiehav beenepenedforuchprpse.

(@)The ChiefFinancil Offier shllbe resposibleforthe invesment and Fund.O n o befor Dece mber31 of eah year theChief reinvestmentof moniesin th vailabl onlne, FnancialOffice shal isue apublc reprt,freeof carge and a secifyig:

() An invenory ofFund investmens asof September 3;

and () The ne income th Fund earnedforthe piorfiscl yar.

Sec.5.

Cration oftheOpioid Abatement AdvisoryCo mmission.

(a)There i estblishe an OpioidAbatemen tAdvisory Commissi on (“Commission”) (b)Th epurpose oftheCom mission istoensurethatthefunds te Ditric recives and dpositsintotheOpioid Abatement Fund arespenton infastrctur, progrms, ls andresourcesforprevenion, teatment recoery, andhar m serices supprts,too ngsubstanceuse andmental helth redution fr opiid usedisorderand c-occurri caing disodersand toensure pblic inolvement, acountbility andtransparencyinallo 2u1 and acconting fo thee funs.

()Th eCom mission shll becompo sedof 11 members, andshal incude:

(1)The AttorneyGeneral ortheAttorneyGeneral'sdesignee;

(2)The Directrofthe Department of Halth orthatDiretor'sdesignee (3)The Directr oftheDepartment of Bhavioral Heath orthatDirecor's designe;

(4)The Chairpersoo fthe Counil’s Committee on Healh orthat Chairperon’s desgnee;

(5)Fourmembersa ppointedbyt heMayor,t oinclue:

(aAnindvdalwohasepeincinpovdngpevnin, eucinsevcsfoopodusdioreandc-ocrrng tratet,rcveyorhamr subtncuseadmetaheatdiores (b A idvdulwh hsepets,epeinc,oeduaioin pubiheatpolcorrserhmedcneormetlhelhsevcs ()n idvdulwh hsexeiecdopoius dsreradco hdioresanreovr;an ocrrnsubtacuseadmetaheat ()Afaiymemerof prsnorecdetwhohdopoiuse dsrdradcoocurigsbsaneuean mnalhalhdsrer;

(6Thrememersaponedb teCuci,tincue ()A idviulwh hsexereceiprviigprvnto, ordradcoocurig tetmn,rcoey,oharredcioseviefoopiiuseds sbsaceueanmenalhathdsres;

()Aniniiulwhohaexetseexeiec,oreuatoni pblchathplcyoreerc,mdiie,ometaheatsevie;ad ()Anidiiulwhohsexereneopiiusedsodranco ocurngsbsaceueanmenalhathdsreran rcvey (dTheMaorshldeinaeteChirothComisio.

(eEacappitemembesha sreathe-eatem ecpttaupon ceainofheCmmsson teMyorsa deinteoeofteMaorsapoitest srvfoaniniloe-ertemandoetoerefraniiitwoyertrmandte artrmadon Cunilsa dsinaeoeoitappitestserefra itaoney tserefra itatwoyartr.Membrsshlconiuetsevetteexiaioof thertermsunilther rplacemnts hve bee appinted Vacanciesshllbe flldinthe same mannerastheoriinalappoitment frtheremaindr ofth tem.

A Commission membe rmay serv amax imum oftwoful tems,withparia ter sericeand appointentsnot cuntedtowardthi maximum.

(6 A Commissionmem bermay be remoed bytheappointngauthoityfor faiuretoattndatleas one -hofthe sceduledmeetins inaone-yer peiodorfor ‘unthcal dshonet orbadfaihcondut.

(g)Commission members sal sevewithoutcompenstion bt sallbe reimburse fo neessaryexpeses icurre i caryingoutdutesrequredby th Commission tha ae i aditin t atendace ameetins.

Sc.6.Operatins o th Commssion.

()The Commissionshal hod pulicmeetins atlestqurtely,withmeetins clle bytheChairora maorityofCommission memers.

Me mbers mayatten i prsonor rmotelythroug audo oraudovisul mans.

Meetingsshalbe pulicied andconduced i amanner tatallos Ditrctresient toatendand prtiipae i- pesonor rmotelythroug liv-stramaudiooraudiovsualmeans.

() Amajoriyofthe Commision’s members sal costiuteaquorum, an ation oftheCommission sal betakenbyan afirmaivevoteo a mjorit ofmembers inatendanc a ameetingwherea quorum ipresnt.

()Me mbers sal dscloe cnflctsofintre t te Cmmission andrefrin frompariciatin i dicussonsand voingon anymatte tatraiessucha coflct Se.

7 Powrs anddutis ofth Commssion.

(a)The Commission shallhave the following powers and duties:

ll ()Esalihplcesadprcduesfrteamiitrtoofth Comision (2Recmmendplcesadprceuesfrteaplcto,awrdn,an disureenofmoie fomteFud rainle,ssanbliypas (3Recomendgas,ojcivsadthi 2m andpefomnc idctrsrltnto 2m ()Pevnio,teamn,reoer,adhar rdctoefotfor uedsodranco-curinsustneusandmntlhelhdiodr;

opiid ()Reucngdsaiieinccsstprvnto,teamn, and rcveyandhamreucinprgrm,sevcssupotstol,adreores ()Imroinheatoutomsintaiinllunereve pplainsinluigpesnsfolo adfomelincreatdidiiul;

awrd omoie fomteFudfothpemisil (4Recomend epedtueseforhiseton4a;

(5RecomendsupesonofaloainofmoiesfomteFudto rcpinsfunbythCommssinorteOfieoOpiidAatmentob sbtataloutocoplanewihthreuiemnsothiralctinorthavuse nd a aarfornunutorzdpupsea (6)SbmtreomendtinstthMayoforppoal (bTheCmmssin’recomedaiosfothaloatooffndacrsaras 286ofte Dsrcshlbebaedotheflowngciraamon ohr:

()Tenumerofeoleprcpiawthaopiiusedsrdrith area;

(2Diprtisiacestocrinanaethtmaypecudpesoswih anopodusdisrerfomotanngadanoiorreevngtetmn;

()Thenumbefoeroseethseraptananre;

sserie,spprstolsorohr (4Theifatrcueprorm resucecuretyaaialtoiniiuaswthsbsaceuedsodrsianae;an (5Dipriisiaccstocreadhelhoucoesianara ec..OfieoOpioidatmet.

a)Theayorhl sabihanOfcefOpoidAbatementie”.The ficehllerom,ataminimum,flowngciiis:

()SupotteatvtesofheCommissiontanngadprviig ulicelhreerchndplcyeprie,fciis,ehnclasstne,ndoher eorcs;

()PrprefrteCommissionviwgas,ojcivs,loatosand hirainls,ssanbliypas,adpefomaceidctrsrltngopevnio, ratet,ecvry,ndharmeutinfroioduseiorerndc-ocrrng ubtnceseadmetalelthiodesandedcngdsaiisinacssto rveton,ramet,ecvr,andharmdutonpogam,srics,upot,tos, and resources;

3)eveopplcesadprcduesfrteapicto,awrdngad isuseentfmoneyromheFn;

()MakeadmanagernsfrmtheFunometappovdgalsnd betie;

3il ()Mantinovrsghofexpndtuesfrm teFud tensrethyar izd s;

mad frauho puros ()PrpaeandsumitttheMayr aqareryacoutinof exenitre fomth Fnd ()ColetdaafromrciintofmoneyfrmtheFud cncrnigth efecivnssfifrstucur,proras,sevie,supotstolsandreouce fndd, inluin:

edprpse;

()How terecpenuse temonesfotherited ()Whereobaialethenuberofinivdal srvdbyrae, ag,generandoterdeogrphicfctr;

()An aalssofwhehe teinrstutue pogam,srvc, supot,tolorreoucereucdmoraltyoimproedprvetin,teamet,hrm reucio,orreovryoucoms;and (DIfaplntoenurthesutinbliyofteinrstutue asummryothe panand proram sric,supot,to,orrsorc fndeexit, (8Cretean minainawesiethtinlue,ataminmum, Commisionmetin atedacerllandmiuts,anuaallcaiosoffnd,reipet awads areeens,an rprt,Oficpolcisan pocdues adtheMyors anul reors (bTheOffceshlemplo aflltieDiecoradadeuatstaftaccoplih theOfie’objctve Se.9.ReprtngandAdit thnDecemer31oeachyea,beinnngon yarateth iiil ()Notlte deostofmoey ittheFud,thMayorshl povdeawrttnreottothCoucil dealigthDisrctsusofmonesinteFundduin tepro fsayea.Thereot shlbepubishdonth OfieofOpoi Aateentswebit.Theannalreorshll inlue ()Theopnin adcloinbalaceo teFud f teficayer;

Fund ()Anaccontngofa cedttoandexenitre fomth Thenamean adscipioofeac rcpin omonisfromthFun, () andthamout aarddtoeacrecpen;

()A dscipioofeacawar’sinenedus,inluinthesecfc proram sric,orrsorc fndd,tepoplaio sred adthemasuesthtte reipenwilusetassssteimpctofteawad;

(5Thepriarycierauedtodterin echreiietandisrspctv awar aoun;

arofthe ifomaioprovde b echreiietpusuntto (6A sum secio8(a();

(7Alitinofllapliatonfora aardofmniesfrmtheFnd recivddurngthficayer;

(8A stteen atowhthe almnie dsbrsdfro teFund suppemetedan ddno sppanorrelaeanyexsinorfuurloclstteorfeeal govenmen fndngand (9Theperfrmaceiniatrsadprorestowrdachevngthgoas adobjcivsfotheficlyarincudngmtrcsonimpovngoutomesanreduin mortalit and oher harmsrelatd toopioi usedisorderand c-occurringsubstanceuse andmental halthdisordrs.

(b)The OfficeoftheDistrit ofColumbia Auditorshal conductan auit o the moniesin te Fund ever fiveyeas.

1.2.

Rule.Definitions.

TheFor Mayor,the pursuntpurposes toTiteof Ithis ftheDistrctofact, Columbiathe Adminstrativeterm: Procedue Act,approved October21, 1968(82 Sat.1204;

D.C.OffiialC(1) ode“Commission” 2-01means etthe sq.),mayOpioid issueruleAbatement toimplementAdvisory theproviionsofCommission thsestablished at.by section 3.

(2) “Evidence-based” means that an activity, practice, program, service, support, or strategy has undergone multiple randomized controlled trials and observational studies demonstrating that it helps individuals avoid the development and progression of opioid and other substance use disorders or drug-related harms, reduces the adverse consequences of opioid and ENGROSSED ORIGINAL other substance use, or manages, slows the progression of, or supports recovery from an opioid use disorder or co-occurring substance use or mental health disorder.

(3) “Evidence-informed” means an activity, practice, program, service, support, or strategy that incorporates the best available evidence, patient needs, values, and preferences, and practitioner expertise into the decision-making process.

(4) “Fund” means the Opioid Abatement Fund established by section 5012 of the Opioid Abatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C.

Law 24- 167;

D.C.

Official Code § 1-325.441).

(5) “Harm reduction” means an activity, practice, program, service, support, or strategy that addresses both conditions that precede and occur as a result of substance use and attempts to reduce the adverse consequences of opioid and other substance use among persons who continue to use those substances.

(6) “Infrastructure” means the resources, such as personnel, buildings, or equipment, required for the District or another entity to provide evidence-based and evidence- informed harm reduction, prevention, recovery, and treatment activities, practices, programs, services, supports, and strategies to individuals with opioid use disorder and co-occurring substance use and mental health disorders.

(7) “Office” means the Office of Opioid Abatement established by section 4.

(8) “Prevention” means primary, secondary, and tertiary efforts to help individuals avoid the development and progression of opioid use disorder and co-occurring substance use and mental health disorders and drug-related harms.

ENGROSSED ORIGINAL (9) “Recovery” means a process through which an individual develops a healthier life, which may include:

(A) Improving the individual’s quality of life, including the individual’s physical and mental health;

(B) The individual’s consistent pursuit of abstinence from the substances or behaviors that have negatively impacted them, their family, and their community;

(C) Relief of the individual’s symptoms, including substance craving;

and (D) Improvement of the individual’s relationships, social connectedness, and interpersonal skills.

(10) “Treatment”:

(A) Means an evidence-based or evidence-informed activity, practice, program, service, support, or strategy to intervene upon, care for, manage, slow the progression of, or support recovery from opioid use disorder or co-occurring substance use or mental health disorders;

(B) Shall be individualized to address each individual’s medical needs;

and (C) Shall include screening for and diagnosis of substance use disorders or co-occurring mental or physical health disorders, as well as pharmacological and non- pharmacological therapeutic interventions for opioid use disorder or co-occurring substance use or mental health disorders.

113. Fisca impactstatemet.

‘TheCouncilOpioid adotsAbatement thAdvisory fisalimpactCommission. satementof th ChiefFinancal Oficer a thefisalimpact statment rquiredby secton4 aof te Genral LegilativeProcedures Actof 1975,approved October 1, 2006(120 Stt.2038;

D.C.OfficilENGROSSED CodeORIGINAL §(a) 1There 301.4a).is established an Opioid Abatement Advisory Commission.

Sc.(b) The purpose of the Commission shall be to:

12.(1) Ensure that the monies the District receives and deposits into the Fund are appropriately expended on evidence-based and evidence-informed harm reduction, prevention, recovery, and treatment activities, practices, programs, services, supports, and strategies for opioid use disorder and co-occurring substance use and mental health disorders;

Efectiv(2) dat.Prioritize and facilitate public involvement, accountability, and transparency in allocating and accounting for these monies;

Thsand actshal(3) taeEnsure efectfollowingapprovalbythat theMayothe r(orinmonies tethe evetofvetDistrict oreceives Mayor,and actondeposits bytheinto Cuncilthe tooverrdeFund thevet),ahave 30-dayperiodofthe byeffect theof ionapreventing, reviewastreating, provideand insectinreducing 602c)(1)ofopioid theDisrictofColumuse biaHdisorder omeand Congressco-occurring vedsubstance Decemberuse 24,1973and (87Statmental 813;D.C.health disorders and reducing fatalities.

Code(c) §The 1-06(c)1)),andCommission Ruleshall Act,approbe publicationcomposed intheof DistrictofColumbia21 Register.members, as follows:

GOVERNMENT(1) OThe FDirector THEDISTRICTof OFthe COLUMDepartment BIAof OFFICEOFTHEATTORNEYBehavioral GENERALHealth, xor ethe *Director’s ATTORNEYdesignee; GNRAL E E KARL A.RACID E E ealCunelivson ORANDUM TO:

EmilyGunston(2) DeputyAttorneyeneralorLgilatveAfairsandPoicyThe FROM:Director of the Department of Health, or the Director’s designee;

BrianK.Flowers(3) LegalCounselThe GeneralDirector DATE:of the Department of Health Care Finance, or the Director’s designee;

July(4) 13,2022The SUBJECT:Deputy Mayor for Health and Human Services, or the Deputy Mayor’s designee;

Lega(5) SufiienyReviewofDratBil,thThe “pioidLiigaioDeputy ProcedsActof2022Mayor (AE-2-555E)for ThPublic isSafety isand toJustice, Ceror tifythe tDeputy hatMayor’s tisoftcehasrevewedthdesignee; abve-efernce leisatonandhasfoun itobelegll sficen.

IyouhaveanyqestiosENGROSSED regrdinORIGINAL tiscetfiaton(6) peasThe dChief noMedical hsiatExaminer, tcontctmeor at72-554.the Chief Medical Examiner’s designee;

Buin(7) 6.The Attorney General, or the Attorney General’s designee;

Flower(8)TheChairperson BrianK.oftheCouncil committeewithjurisdictionoverhealth matters, or the Chairperson’s designee;

Flowers(9) T30PnnyvnaAeueNA,Sie49Wahnto,DC2004(0)7452Five members appointed by the Mayor, with the following qualifications:

(A) One member with experience in providing prevention, recovery, treatment, or harm reduction services for opioid use disorder and co-occurring substance use and mental health disorders;

(B)Twomembers,respectively,withprofessionalexpertiseandeducational backgrounds in:

(i) Medicine;

and (ii) Mental health services;

(C) One member who has experienced opioid use disorder and co-occurring substance use and mental health disorders and recovery;

and (D) One family member of a person or decedent who experienced opioid use disorder and co-occurring substance use and mental health disorders;

(10) One representative each from the:

(A) D.C.

Behavioral Health Association;

(B) Medical Society of D.C.;

(C) D.C.

Primary Care Association;

and (D) D.C.

Hospital Association;

and ENGROSSED ORIGINAL (11) Four members appointed by the Chairman of the Council, with the following qualifications:

(A) Two members with current experience as direct service providers of prevention, recovery, treatment, or harm reduction services for opioid use disorder and co- occurring substance use and mental health disorders;

(B)Onememberwithprofessionalexpertiseandaneducationalbackground in public health policy or research;

and (C) One member who has experienced opioid use disorder and co-occurring substance use and mental health disorders and recovery.

(d) The Commission shall elect a Chair from among its members.

(e)(1) Each member appointed pursuant to subsection (c)(9) and (11) of this section shall serve a 3-year term;

except, that:

(A) Of the Mayor’s initial appointments, 2 members shall be appointed for terms of one year, and 2 members shall be appointed for terms of 2 years;

and (B) Of the Council’s initial appointments, one member shall be appointed for a term of one year, and 2 members shall be appointed for terms of 2 years.

(2) Members shall serve:

(A) Following the expiration of their terms until their successors have been appointed;

(B) For a maximum of 2 full terms, with partial term service not counted toward this maximum;

and ENGROSSED ORIGINAL (C) Without compensation;

provided, that they shall be reimbursed for necessary expenses incurred in carrying out Commission duties.

(3) Vacancies shall be filled in the same manner as the original appointment for the remainder of the term.

(f) The Commission shall hold public meetings at least quarterly, with meetings called by the Chair or a majority of Commission members.

All Commission meetings shall be subject to the Open Meetings Act, effective March 31, 2011 (D.C.

Law 18-350;

D.C.

Official Code § 2-571 et seq.).

(g) A majority of the Commission’s members shall constitute a quorum, and actions of the Commission shall be taken by an affirmative vote of a majority of the members in attendance at a meeting where a quorum is present.

Members may attend in person or remotely through audio or audiovisual means.

(h) The Commission shall have the following powers and duties:

(1) Establish procedures for the Commission’s operations;

and (2) Make recommendations to the Mayor and Council regarding:

(A) District-wide goals, objectives, and performance indicators relating to:

(i) Prevention, recovery, treatment, and harm reduction infrastructure, activities, practices, programs, services, supports, and strategies for opioid use disorder and co-occurring substance use and mental health disorders;

ENGROSSED ORIGINAL (ii) Reducing disparities in access to prevention, recovery, treatment, and harm reduction infrastructure, activities, practices, programs, services, supports, and strategies;

and (iii) Improving outcomes and reducing mortality in traditionally underserved populations, including for communities of color and current or formerly incarcerated individuals, with regard to prevention, recovery, treatment, and harm reduction infrastructure, activities, practices, programs, services, supports, and strategies;

(B) Governing principles, policies, and procedures for the application for and awarding of monies and grants from the Fund;

(C) Awards of monies and grants from the Fund;

(D) The performance and outcomes of Fund awardees and grantees;

(E) Management of the Fund;

and (F) Any changes to the Fund’s purposes.

(i) The Commission’s recommendations for the awarding of monies and grants pursuant to subsection (h)(2)(C) of this section shall include the consideration of the following:

(1) The number of individuals, per capita, with an opioid use disorder, and the number of overdose deaths per capita, in the area which a prospective awardee or grantee seeks to serve;

(2)Disparities in access tocare andhealthoutcomes in the areawhich a prospective awardee or grantee seeks to serve;

and ENGROSSED ORIGINAL (3) The infrastructure, activities, practices, programs, services, supports, and strategies currently available to individuals with an opioid use disorder in an area which a prospective awardee or grantee seeks to serve.

Sec.

4.

Office of Opioid Abatement.

(a)(1) There is established, within the Department of Behavioral Health, an Office of Opioid Abatement.

(2) The Office shall be led by a Director with at least 10 years’ professional.

experience and education in prevention, recovery, treatment, and harm reduction efforts for opioid use disorder and co-occurring substance use and mental health disorders.

(b) The Office shall have the following powers and duties:

(1) Conducting a District-wide needs assessment to identify structural gaps and needs related to opioid use disorder and co-occurring substance use and mental health disorders;

(2) Supporting the Commission’s activities by providing staffing, research and policy expertise, facilities, technical assistance, and other resources;

(3) Assisting the Commission in preparing its recommendations regarding goals, objectives, and performance indicators pursuant to section 3(h)(2)(A);

(4) Integrating the work of the Office and Commission and Fund expenditures with existing District strategic planning related to opioid use disorder and co-occurring substance use and mental health disorders;

(5) Developing governing principles, policies, and procedures for the application and awarding of monies and grants from the Fund;

ENGROSSED ORIGINAL (6) Overseeing expenditures from the Fund, including by preparing a quarterly accounting of expenditures from the Fund and the Fund balance;

(7) Issuing, managing, and overseeing awards and grants from the Fund, including collecting and publicly reporting data from awardees and grantees concerning the effectiveness of infrastructure, activities, practices, programs, services, supports, and strategies funded;

and (8)Preparingtheannualreportrequiredbysection5012(f)oftheOpioidAbatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C.

Law 24-167;

D.C.

Official Code § 1-325.441(f));

and (9) Creating and maintaining a public website that includes:

(A) Commission meeting attendance, agendas, and minutes;

(B) The governing principles, policies, and procedures developed pursuant to paragraph (5) of this subsection;

(C) The quarterly accountings of Fund expenditures and Fund balance prepared pursuant to paragraph (6) of this subsection;

(D) A listing of awards and grants from the Fund and awardee and grantee data collected pursuant to paragraph (7) of this subsection;

and (E) The annual reports prepared pursuant to section 5012(f) of the Opioid Abatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C.

Law 24-167;

D.C.

Official Code § 1-325.441(f)).

(c) If the Office decides not to follow a Commission recommendation in whole or in part, the Office shall provide the Commission with a written explanation for its decision within 14 days ENGROSSED ORIGINAL after the decision is made.

The Commission shall have at least 7 days after receipt of the Office’s written explanation to provide a written response before the Office proceeds with its decision.

Sec.

5.

Rules.

The Mayor, pursuant to Title I of the District of Columbia Administrative Procedure Act, approved October 21, 1968 (82 Stat.

1204;

D.C.

Official Code 2-501 et seq.), may issue rules to implement the provisions of this act.

Sec.

6.

Section 106b of the Attorney General for the District of Columbia Clarification and Elected Term Amendment Act of2010,effectiveOctober22,2015(D.C.Law21-36;

D.C.Official Code § 1-301.86b), is amended as follows:

(a) Subsection (b) is amended as follows:

(1) Paragraph (2) is amended by striking the phrase “;

and” and inserting a semicolon in its place.

(2) Paragraph (3) is amended by striking the period and inserting the phrase “;

and” in its place.

(3) A new paragraph (4) is added to read as follows:

“(4)Subject to thelimitations ofsubsection(d)(3)(D)ofthis section,funds received pursuant to section 5012(b)(1)and (1A)oftheOpioidAbatement Fund Establishment Act of2022, effective September 21, 2022 (D.C.

Law 24-167;

D.C.

Official Code § 1-325.441(b)(1), (1A)).”.

(b) Subsection (d)(3)(D) is amended to read as follows:

“(D) The Attorney General shall transfer to the Opioid Abatement Fund, established by section 5012 of the Opioid Abatement Fund Establishment Act of 2022, effective ENGROSSED ORIGINAL September 21, 2022 (D.C.

Law 24-167;

D.C.

Official Code § 1-325.441), at least 85% of any payment received prior to October 1, 2022, in settlement of the cases and settlements, judgments, and consent decrees specified in section 5012(b)(1) and (1A) of the Opioid Abatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C.

Law 24-167;

D.C.

Official Code § 1-325.441(b)(1), (1A)), that was deposited into the Fund, and at least 90% of any payment received thereafter.

The Attorney General may elect to retain the remainder of each such payment in the Fund by providing the Mayor, Chief Financial Officer, and Council with written notice of the amount of the election and the relevant payment.

In making this election, the Attorney General shall ensure compliance with all applicable settlement terms.”.

Sec.

7.

Section 5012 of the Opioid Abatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C.

Law 24-167;

D.C.

Official Code § 1-325.441), is amended as follows:

(a) Subsection (a) is amended by striking the phrase “the Mayor” and inserting the phrase “the Department of Behavioral Health” in its place.

(b) Subsection (b) is amended as follows:

(1) Paragraph (1) is amended as follows:

(A) The lead-in language is amended by striking the phrase “time, in settlement of D.C.

Superior Court cases” and inserting the phrase “time, pursuant to the settlement and trust-distribution agreements entered in the following cases” in its place.

(B) Subparagraph (A) is amended by striking the phrase “Case No.

2022- CA-001441-B” and inserting the phrase “Case No.

2022-CA-001441-B (D.C.

Super.

Ct.)” in its place.

ENGROSSED ORIGINAL (C) Subparagraph (B) is amended to read as follows:

“(B) District of Columbia v.

McKesson Corp., et al., Case No.

2022-CA- 001401-B (D.C.

Super.

Ct.);”.

(D) Subparagraph (C) is amended by striking the phrase “Case No.

2021- CA-00327-B;

and” and inserting the phrase “Case No.

2021-CA-00327-B (D.C.

Super.

Ct.);

and” in its place.

(E) A new subparagraph (D) is added to read as follows:

“(D) In re Mallinckrodt PLC, No.

20-BK-12522 (Bankr.

D.

Del.);” (2) A new paragraph (1A) is added to read as follows:

“(1A) Funds received by the District pursuant to any pre- or post-suit settlement, judgment, or consent decree that the Attorney General designates as an opioid-related settlement, judgment, or consent decree;

provided, that the Attorney General shall notify the Mayor and Council of any such designation within 30 days after the settlement, judgment, or consent decree becoming final;

and”.

(c) New subsections (b-1), (b-2), (b-3), and (b-4) are added to read as follows:

“(b-1) Monies in the Fund shall only be used for the following purposes:

“(1) Permissible Commission and Office activities and operations, including personnel, pursuant to sections 3 and 4, respectively;

“(2) District-wide needs assessments to identify structural gaps and needs related to opioid use disorder and co-occurring substance use and mental health disorders;

ENGROSSED ORIGINAL “(3) Awards and grants for evidence-based and evidence-informed prevention, recovery, treatment, or harm reduction activities, practices, programs, services, supports, and strategies for opioid use disorder and co-occurring substance use and mental health disorders, including evidence-informed pilot programs or demonstration studies;

“(4) Infrastructure required for evidence-based and evidence-informed prevention, recovery, treatment, or harm reduction activities, practices, programs, services, supports, and strategies for opioid use disorder and co-occurring substance use and mental health disorders;

“(5) Evaluations of effectiveness and outcomes for activities, practices, programs, services, supports, and strategies for opioid use disorder and co-occurring substance use and mental health disorders for which monies from the Fund were disbursed, such as impact on access to harm reduction, services, or treatment for disorders, or reduction in drug-related mortality;

“(6) Publicly available data interfaces, including to aggregate, track, and report:

“(A)Dataon opioidusedisorderandco-occurringsubstanceuseandmental health disorders, overdoses, and drug-related harms;

and “(B) Outcomes of activities, practices, programs, services, supports, and strategies for which monies from the Fund were disbursed;

“(7) The audit required by subsection (g) of this section;

and “(8) Any other opioid abatement activities authorized by any settlement, judgment, or consent decree resulting in funds being deposited into the Fund.

“(b-2) Unless otherwise required by court order, monies in the Fund shall be used for prospective purposes and not to reimburse expenditures incurred prior to the effective date of the ENGROSSED ORIGINAL Opioid Litigation Proceeds Amendment Act of 2022, as approved by the Committee on the Judiciary and Public Safety on November 22, 2022 (Committee print of Bill 24-952).

“(b-3) Monies expended from the Fund for the purposes set forth in subsection (b-1) of this sectionshallsupplement,andnotsupplant,anyotherfunds,includinginsurancebenefitsorDistrict or federal funding, that would otherwise have been expended for such purposes.

“(b-4) Expenditures for Commission and Office activities and operations, including personnel, and expenditures for audits shall comply with any applicable terms in the settlement agreements,judgments,orconsentdecreesthatlimittheuseoffundsforadministrativeexpenses.”.

(d) Subsection (c) is amended by striking the phrase “the Council of the District of Columbia” and inserting the phrase “the Council” in its place.

(e) New subsections (e), (f), and (g) are added to read as follows:

“(e)(1) Notwithstanding subsection (b)(1) and (1A) of this section, the Attorney General may elect to have no more than 15% of any payment the District receives prior to October 1, 2022, pursuant to the settlements, judgments, and consent decrees referenced in subsection (b)(1) and (1A) of this section, retained in the Litigation Support Fund established pursuant to section 106b of the Attorney General for the District of Columbia Clarification and Elected Term Amendment Act of 2010, effective October 22, 2015 (D.C.

Law 21-36;

D.C.

Official Code § 1-301.86b), and no more than 10% of any payment received thereafter.

“(2) The Attorney General shall make an election pursuant to paragraph (1) of this subsection by providing the Mayor, Chief Financial Officer, and Council with written notice of ENGROSSED ORIGINAL the amount of the election and the relevant payment.

In making this election, the Attorney General shall ensure compliance with all applicable settlement terms.

“(f)(1) No later than December 31 of each year, the Department of Behavioral Health shall provide a report to the Mayor, Council, and Attorney General detailing the District’s use of monies in the Fund during the prior fiscal year.

“(2) The annual report required by paragraph (1) of this subsection shall:

“(A) Be published on the Office of Opioid Abatement’s website;

and “(B) Include, for the prior fiscal year:

“(i) The opening and closing balance of the Fund;

“(ii)An accountinganddescriptionofall credits toandexpenditures from the Fund;

“(iii) An inventory of Fund investments, as of September 30 of the prior fiscal year;

“(iv) The net income the Fund earned;

“(v) A listing of all applications received for awards and grants of monies from the Fund;

“(vi) The name and a description of each awardee or grantee of monies from the Fund, and the amount disbursed to each awardee or grantee;

“(vii) A description of the intended use of each award or grant from the Fund, including the activity, practice, program, service, support, or strategy funded, population served, and measures that the awardee or grantee will use to assess the impact of the award;

ENGROSSED ORIGINAL “(viii) The primary criteria used to select each awardee or grantee and its respective award or grant amount;

“(ix) A statement as to whether monies disbursed from the Fund supplemented and did not supplant or replace any existing or future local, state, or federal government funding;

and “(x) The progress toward achieving the Commission, Office, and Fund’s purposes, such as metrics on improving outcomes and reducing mortality and other harms related to opioid use disorder and co-occurring substance use and mental health disorders.

“(g) The Office of the District of Columbia Auditor shall audit the Fund every 5 years.”.

Sec.

8.

Applicability (a) This act shall apply upon the date of inclusion of its fiscal effect in an approved budget and financial plan.

(b) The Chief Financial Officer shall certify the date of the inclusion of the fiscal effect in an approved budget and financial plan, and provide notice to the Budget Director of the Council of the certification.

(c)(1) The Budget Director shall cause the notice of the certification to be published in the District of Columbia Register.

(2) The date of publication of the notice of the certification shall not affect the applicability of this act.

Sec.

9.

Fiscal impact statement.

ENGROSSED ORIGINAL The Council adopts the fiscal impact statement in the committee report as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat.

2038;

D.C.

Official Code § 1-301.47a).

Sec.

10.

Effective date.

This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat.

813;

D.C.

Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.

18